Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Report ID | 227019 |
Drug Identification Number | 02362627 |
Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Common or Proper name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | TAZOBACTAM PIPERACILLIN |
Strength(s) | 0.375G 3.000G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 VIALS |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2024-05-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-05-03 |
Company comments | Product remains available at McKesson. Contract coverage is in place. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-05-03 | French | Compare |
v1 | 2024-05-03 | English | Compare |
Showing 1 to 2 of 2